Eli Lilly announced a partnership with chipmaker NVIDIA to build what it claims will be the “most powerful supercomputer ...

Eli Lilly said on Wednesday it will invest more than $1.2 billion to expand its manufacturing site in Puerto Rico, as the ...

The company's multibillion-dollar investments in manufacturing in the U.S. are likely to be warmly welcomed by the Trump administration. Eli Lilly's management has already committed to taking action ...

Eli Lilly was looking for infrastructure and an uncomplicated permit process for its $6.5M pharmaceutical manufacturing ...

Mounjaro and Zepbound have helped boost the company's market cap. New data indicate these drugs do more than just help patients lose weight, contributing to potentially lowering risks to hearts and ...

Oct 6 (Reuters) - Eli Lilly (LLY.N), opens new tab will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, ...

Amid Eli Lilly's efforts to strengthen its global manufacturing network, the Indianapolis pharma giant is splashing more than $1 billion into its Indian operations, with plans to tap local partners ...

Eli Lilly is a leader in weight loss drugs, a market that may reach $95 billion by the end of the decade. Viking Therapeutics is heading toward the finish line with a drug that could compete with ...

Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake (Reuters) -Peter Marks, the former top vaccine regulator at the U.S. Food ...

Financial giants have made a conspicuous bullish move on Eli Lilly. Our analysis of options history for Eli Lilly (NYSE:LLY) revealed 18 unusual trades. Delving into the details, we found 50% of ...

Healthcare is underowned; 2026 rate cuts and policy clarity should trigger inflows. As XLV’s largest weight and obesity leader, Lilly will capture outsized demand during the sector re-rating cycle.